Cargando…

The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case–control study

BACKGROUND: Disordered inflammation and immune response is an acknowledged risk factor for cervical cancer development. Interleukin‐1 receptor type 2 (IL1R2) is a decoy receptor for IL‐1 cytokines and involved in host inflammatory and immune progression which could lead to the lesion and neoplasia o...

Descripción completa

Detalles Bibliográficos
Autores principales: Niu, Fanglin, Wang, Tianchang, Li, Jing, Yan, Mengdan, Li, Dianzhen, Li, Bin, Jin, Tianbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382450/
https://www.ncbi.nlm.nih.gov/pubmed/30460760
http://dx.doi.org/10.1002/mgg3.516
_version_ 1783396675605233664
author Niu, Fanglin
Wang, Tianchang
Li, Jing
Yan, Mengdan
Li, Dianzhen
Li, Bin
Jin, Tianbo
author_facet Niu, Fanglin
Wang, Tianchang
Li, Jing
Yan, Mengdan
Li, Dianzhen
Li, Bin
Jin, Tianbo
author_sort Niu, Fanglin
collection PubMed
description BACKGROUND: Disordered inflammation and immune response is an acknowledged risk factor for cervical cancer development. Interleukin‐1 receptor type 2 (IL1R2) is a decoy receptor for IL‐1 cytokines and involved in host inflammatory and immune progression which could lead to the lesion and neoplasia of cervix. In this study, we aimed to evaluate the relationships between IL1R2 polymorphisms and cervical cancer risk in Uygur females from China. METHODS: In this case–control study, genotypes of six selected variants (rs11674595, rs4851527, rs719250, rs3218896, rs3218977, and rs2072472) distributed in IL1R2 were detected among 247 cervical cancer patients and 286 healthy controls with the usage of an Agena MassARRY method. Furthermore, Genetic models and haplotype analyses were conducted to estimate the associations of IL1R2 polymorphisms with cervical cancer risk. RESULTS: After statistical analyses, rs719250 (odd ratio [OR] = 1.436, 95% confidence interval [95% CI] = 1.079–1.911, p = 0.013) and rs3218896 (OR = 1.552, 95% CI = 1.080–2.229, p = 0.017) showed obvious evidence in correlation to cervical cancer susceptibility owing to the surviving significant differences between cases and controls in allele model. Genetic model analyses also revealed significant associations of rs719250 and rs3218896 with cervical cancer risk in the codominant model, the dominant model and the log‐additive model even after adjustment for age (p < 0.05). Moreover, haplotype “T/A” of rs11674595/rs4851527 (adjusted OR = 0.73, 95% CI = 0.54–0.98, p = 0.037) and “T/C” of rs719250/rs3218896 (adjusted OR = 1.61, 95% CI = 1.10–2.36, p = 0.015) exhibited protective and risky effects for Uygur individuals on cervical cancer development, respectively. CONCLUSION: Our data first shed the new light on the associations of IL1R2 polymorphisms with cervical cancer susceptibility among Uygur females. These results are supposed to facilitate the tumorigenesis genetic research among Chinese minorities.
format Online
Article
Text
id pubmed-6382450
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63824502019-03-01 The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case–control study Niu, Fanglin Wang, Tianchang Li, Jing Yan, Mengdan Li, Dianzhen Li, Bin Jin, Tianbo Mol Genet Genomic Med Original Articles BACKGROUND: Disordered inflammation and immune response is an acknowledged risk factor for cervical cancer development. Interleukin‐1 receptor type 2 (IL1R2) is a decoy receptor for IL‐1 cytokines and involved in host inflammatory and immune progression which could lead to the lesion and neoplasia of cervix. In this study, we aimed to evaluate the relationships between IL1R2 polymorphisms and cervical cancer risk in Uygur females from China. METHODS: In this case–control study, genotypes of six selected variants (rs11674595, rs4851527, rs719250, rs3218896, rs3218977, and rs2072472) distributed in IL1R2 were detected among 247 cervical cancer patients and 286 healthy controls with the usage of an Agena MassARRY method. Furthermore, Genetic models and haplotype analyses were conducted to estimate the associations of IL1R2 polymorphisms with cervical cancer risk. RESULTS: After statistical analyses, rs719250 (odd ratio [OR] = 1.436, 95% confidence interval [95% CI] = 1.079–1.911, p = 0.013) and rs3218896 (OR = 1.552, 95% CI = 1.080–2.229, p = 0.017) showed obvious evidence in correlation to cervical cancer susceptibility owing to the surviving significant differences between cases and controls in allele model. Genetic model analyses also revealed significant associations of rs719250 and rs3218896 with cervical cancer risk in the codominant model, the dominant model and the log‐additive model even after adjustment for age (p < 0.05). Moreover, haplotype “T/A” of rs11674595/rs4851527 (adjusted OR = 0.73, 95% CI = 0.54–0.98, p = 0.037) and “T/C” of rs719250/rs3218896 (adjusted OR = 1.61, 95% CI = 1.10–2.36, p = 0.015) exhibited protective and risky effects for Uygur individuals on cervical cancer development, respectively. CONCLUSION: Our data first shed the new light on the associations of IL1R2 polymorphisms with cervical cancer susceptibility among Uygur females. These results are supposed to facilitate the tumorigenesis genetic research among Chinese minorities. John Wiley and Sons Inc. 2018-11-20 /pmc/articles/PMC6382450/ /pubmed/30460760 http://dx.doi.org/10.1002/mgg3.516 Text en © 2018 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Niu, Fanglin
Wang, Tianchang
Li, Jing
Yan, Mengdan
Li, Dianzhen
Li, Bin
Jin, Tianbo
The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case–control study
title The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case–control study
title_full The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case–control study
title_fullStr The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case–control study
title_full_unstemmed The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case–control study
title_short The impact of genetic variants in IL1R2 on cervical cancer risk among Uygur females from China: A case–control study
title_sort impact of genetic variants in il1r2 on cervical cancer risk among uygur females from china: a case–control study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382450/
https://www.ncbi.nlm.nih.gov/pubmed/30460760
http://dx.doi.org/10.1002/mgg3.516
work_keys_str_mv AT niufanglin theimpactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT wangtianchang theimpactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT lijing theimpactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT yanmengdan theimpactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT lidianzhen theimpactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT libin theimpactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT jintianbo theimpactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT niufanglin impactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT wangtianchang impactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT lijing impactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT yanmengdan impactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT lidianzhen impactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT libin impactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy
AT jintianbo impactofgeneticvariantsinil1r2oncervicalcancerriskamonguygurfemalesfromchinaacasecontrolstudy